U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Morbidity and Mortality Weekly Report (MMWR)

CDC Stacks Public Health Publications

The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.

(58)
(67)
(184)
(230)
(500)
(673)
(659)
(403)
(489)
(557)
(246)
(325)
(427)
(406)
(97)
(156)
(103)
(110)
(97)
(92)
(119)
(92)
(108)
(96)
(97)
(92)
(79)
(97)
(87)
(91)
(88)
(76)
(74)
(84)
(80)
(69)
(70)
(73)
(68)
(69)
(59)
(67)
(62)
(64)
(62)
(66)
(72)
(55)
(53)
(55)
(60)
(56)
(58)
(54)
(53)
(56)
(55)
(52)
(54)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(51)
0 of 75
(57)
(63)
(187)
(223)
(500)
(663)
(656)
(409)
(483)
(558)
(231)
(311)
(436)
(413)
(91)
(148)
(100)
(104)
(102)
(92)
(120)
(92)
(104)
(97)
(97)
(91)
(80)
(97)
(86)
(90)
(87)
(76)
(75)
(84)
(80)
(69)
(69)
(71)
(69)
(64)
(60)
(68)
(62)
(62)
(62)
(67)
(72)
(56)
(55)
(54)
(59)
(57)
(58)
(54)
(53)
(55)
(55)
(55)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
0 of 75
(1)
(7)
(33)
(71)
(44)
(137)
(157)
(161)
(151)
(137)
(163)
(169)
(155)
(160)
(161)
(157)
(164)
(165)
(157)
(165)
(157)
(174)
(142)
(156)
(159)
(135)
(156)
(141)
(142)
(141)
(137)
(138)
(142)
(131)
(162)
(144)
(136)
(152)
(152)
(177)
(206)
(197)
(165)
(187)
(179)
(201)
(205)
(202)
(223)
(226)
(232)
(221)
(225)
(252)
(252)
(278)
0 of 56
(2)
(1)
(4)
(431)
(108)
(406)
(13)
(8560)
0 of 8
(16)
(34)
(2)
(6)
(40)
(4)
(1)
(1)
0 of 8
(10)
(18)
(10)
(9)
(11)
(10)
(25)
(11)
(7)
(27)
(21)
(42)
(7)
(58)
(7)
(23)
(13)
(38)
(10)
(10)
(50)
(8)
(1237)
(23)
(1293)
(32)
(71)
(91)
(27)
(16)
(7)
(128)
(70)
(790)
(24)
(198)
(39)
(61)
(38)
(19)
(26)
(20)
(15)
(26)
(9)
(11)
(17)
(10)
(7)
(49)
(11)
(8)
(224)
(17)
(17)
(8)
(181)
(137)
(130)
(33)
(8)
(15)
(13)
(9)
(10)
(13)
(15)
(9)
(15)
(8)
(30)
(18)
(10)
(7)
(18)
(99)
(13)
(12)
(36)
(8)
(18)
(12)
(7)
(13)
(11)
(30)
(10)
(28)
(9)
(9)
(15)
(21)
(8)
(17)
(7)
(8)
(31)
(77)
(60)
(8)
(7)
(14)
(12)
(13)
(15)
(19)
(11)
(85)
(13)
(14)
(31)
(13)
(30)
(14)
(12)
(187)
(7)
(7)
(17)
(8)
(18)
(53)
(11)
(10)
(8)
(24)
(21)
(691)
(8)
(11)
(15)
(59)
(205)
(7)
(9)
(18)
(10)
(66)
(14)
(23)
(7)
(17)
(22)
(21)
(7)
(15)
(10)
(9)
(24)
(13)
(31)
(20)
(7)
(13)
(29)
(13)
(31)
(74)
(26)
(20)
(7)
(7)
(8)
(13)
(28)
(25)
(9)
(941)
(9)
(14)
(14)
(740)
(35)
(103)
(10)
(51)
(10)
(20)
(11)
(11)
(9)
(58)
(12)
(20)
(14)
(49)
(20)
(21)
(19)
(20)
(16)
(177)
(81)
(2981)
(316)
(263)
(12)
(543)
(215)
(37)
(38)
(25)
(14)
(15)
(14)
(12)
(34)
(10)
(80)
(14)
(11)
(8)
(23)
(8)
(8)
(439)
(23)
(15)
(8)
(73)
(19)
(28)
(31)
(24)
(10)
(18)
(18)
(18)
(45)
(74)
(8)
(40)
(11)
(8)
(11)
(20)
(19)
(58)
(9)
(23)
(8)
(16)
(34)
(44)
(83)
(9)
(10)
(9)
(21)
(65)
(13)
(14)
(28)
(25)
(14)
(10)
(10)
(8)
(166)
(26)
(11)
(14)
(35)
(24)
(9)
(9)
(24)
(26)
(12)
(92)
(4171)
(642)
(34)
(12)
(17)
(14)
(11)
(10)
(12)
(13)
(9)
(28)
(16)
(19)
(8)
(12)
(27)
(17)
(46)
(20)
(28)
(36)
(10)
(20)
(21)
(8)
(8)
(8)
(66)
(91)
(9)
(25)
(27)
(13)
(21)
(22)
(8)
(39)
(56)
(69)
(21)
(15)
(149)
(16)
(14)
(8)
(12)
(32)
(19)
(19)
(16)
(22)
(10)
(11)
(144)
(45)
(32)
(9)
(41)
(15)
(32)
(660)
(26)
(9)
(56)
(14)
(130)
(9)
(18)
(62)
(10)
(10)
(30)
(11)
(10)
(13)
(21)
(8)
(15)
(23)
(111)
(23)
(1338)
(15)
(10)
(17)
(11)
(13)
(8)
(8)
(48)
(8)
(42)
(45)
(25)
(47)
(13)
(25)
(186)
(14)
(16)
(11)
(586)
(394)
(15)
(21)
(14)
(152)
(16)
(53)
(9)
(28)
(10)
(19)
(162)
(8)
(10)
(14)
(31)
(9)
(8)
(9)
(19)
(11)
(8)
(8)
(110)
(10)
(78)
(11)
(68)
(60)
(17)
(23)
(60)
(132)
(19)
(105)
(58)
(12)
(39)
(126)
(35)
(97)
(52)
(17)
(10)
(11)
(12)
(12)
(8)
(14)
(52)
(71)
(116)
(173)
(25)
(17)
(50)
(13)
(10)
(33)
(12)
(10)
(46)
(8)
(29)
(11)
(8)
(8)
(60)
(31)
(90)
(44)
(12)
(28)
(51)
(9)
(207)
(18)
(32)
(17)
(19)
(2446)
(16)
(19)
(18)
(11)
(106)
(8)
(207)
(232)
(20)
(38)
(23)
(8)
(8)
(9)
(18)
(240)
(11)
(49)
(678)
(47)
(10)
(308)
(15)
(63)
(23)
(17)
(8)
(21)
(188)
(54)
(48)
(8)
(45)
(114)
(50)
(125)
(28)
(11)
(10)
(596)
(15)
(22)
(13)
(61)
(9)
(26)
(29)
(14)
(37)
(12)
(8)
(32)
(12)
(22)
(8)
(8)
(22)
(13)
(16)
(11)
(10)
(73)
(9)
(10)
(10)
(74)
(32)
(114)
(9)
(13)
(41)
(17)
(55)
(17)
(13)
(16)
(18)
(10)
(17)
(44)
(66)
(10)
(11)
(9)
(10)
(12)
(177)
(12)
(14)
(17)
(1181)
(9)
(9)
(8)
(50)
(10)
(44)
(109)
(10)
(16)
(8)
(19)
(312)
(33)
(23)
(12)
(9)
(84)
(11)
(12)
(41)
(11)
(18)
(20)
(8)
(11)
(8)
(8)
(19)
(58)
(32)
(82)
(14)
(37)
(8)
(21)
(40)
(13)
(17)
(17)
(9)
(9)
(66)
(19)
(963)
(103)
(15)
(48)
(30)
(8)
(11)
(57)
(3831)
(11)
(9)
(9)
(29)
(8)
(22)
(16)
(16)
(15)
(17)
(10)
(8)
(13)
(8)
(11)
(18)
(9)
(14)
(15)
(9)
(16)
(41)
(43)
(20)
(10)
(27)
(11)
(12)
(10)
(15)
(243)
(18)
(22)
(36)
(8)
(15)
(113)
(10)
(257)
(611)
(72)
(11)
(23)
(17)
(8)
(11)
(15)
(9)
(10)
(10)
(301)
(12)
(11)
(8)
(14)
(12)
(11)
(20)
(10)
(10)
(16)
(13)
(13)
(22)
(10)
(10)
(65)
(10)
(9)
(10)
(9)
(19)
(12)
(9)
(144)
(18)
(15)
(8)
(33)
(144)
(22)
(11)
(171)
(10)
(8)
(8)
(70)
(30)
(25)
(21)
(343)
(24)
(115)
(36)
(11)
(8)
(84)
(34)
(14)
(8)
(10)
(21)
(29)
(20)
(16)
(1141)
(18)
(27)
(18)
(22)
(110)
(15)
(22)
(23)
(349)
(19)
(72)
(16)
(26)
(14)
(15)
(10)
(26)
(35)
(10)
(9)
(11)
(216)
(50)
(16)
(23)
(34)
(21)
(10)
(19)
(74)
(20)
(9)
(233)
(1005)
(22)
(24)
(71)
(101)
(2519)
(11)
(104)
(12)
(23)
(15)
(16)
(14)
(93)
(177)
(38)
(14)
(11)
(279)
(15)
(9)
(13)
(45)
(8)
(32)
(91)
(9)
(17)
(18)
(11)
(23)
(71)
(37)
(18)
(12)
(8)
(12)
(21)
(10)
(28)
(10)
(10)
(8)
(24)
(104)
(187)
(28)
(29)
(25)
(10)
(20)
(9)
(58)
(195)
(303)
(67)
(8)
(21)
(12)
(8)
(59)
(18)
(34)
(9)
(38)
(177)
(10)
(617)
(31)
(32)
(146)
(241)
(12)
(18)
(10)
(8)
(122)
(11)
(126)
(9)
(16)
(18)
(15)
(20)
(11)
(9)
(19)
(11)
(28)
(35)
(37)
(11)
(8)
(65)
(22)
(42)
(14)
(16)
(28)
(10)
(10)
(14)
(12)
(80)
(31)
(8)
(39)
(9)
(20)
(18)
(12)
(184)
(28)
(9)
(23)
(71)
(25)
(23)
(25)
(14)
(8)
(9)
(108)
(8)
(22)
(16)
(44)
(16)
(134)
(51)
(10)
(19)
(10)
(56)
(10)
(8)
(12)
(18)
(94)
(31)
(35)
(12)
(49)
(8)
(38)
(91)
(9)
(22)
(14)
(183)
(8)
(11)
(8)
(19)
(33)
(21)
(19)
(12)
(8)
(69)
(9)
(54)
(15)
(12)
(8)
(15)
(8)
(8)
(10)
(58)
(19)
(182)
(28)
(36)
(22)
(106)
(19)
(157)
(9)
(12)
(15)
(13)
(68)
(9)
(14)
(182)
(10)
(10)
(19)
(62)
(13)
(29)
(17)
(50)
(17)
(19)
(9)
(14)
(466)
(48)
(50)
(105)
(11)
(17)
(104)
(8)
(29)
(24)
(34)
(21)
(40)
(10)
(23)
(31)
(20)
(35)
(21)
(18)
(12)
(8)
(43)
(94)
(22)
(26)
(9)
(23)
(9)
(12)
(8)
(39)
(14)
(14)
(59)
(11)
(9)
(38)
(17)
(16)
(39)
(16)
(78)
(8)
(43)
(13)
(15)
(10)
(46)
(27)
(762)
(30)
(57)
(10)
(12)
(29)
(33)
(10)
(10)
(8)
(14)
(51)
(8)
(61)
(16)
(9)
0 of 1000
(12)
(12)
(15)
(7)
(23)
(9)
(7)
(18)
(8)
(7)
(10)
(11)
(7)
(9)
(7)
(10)
(9)
(11)
(11)
(19)
(9)
(11)
(9)
(10)
(27)
(8)
(9)
(12)
(23)
(15)
(9)
(7)
(7)
(7)
(9)
(13)
(11)
(9)
(15)
(7)
(7)
(7)
(7)
(9)
(8)
(19)
(9)
(9)
(7)
(7)
(13)
(7)
(7)
(9)
(7)
(9)
(7)
(16)
(13)
(7)
(12)
(12)
(22)
(28)
(15)
(8)
(8)
(13)
(7)
(19)
(12)
(12)
(13)
(15)
(16)
(9)
(10)
(7)
(11)
(28)
(7)
(13)
(28)
(7)
(10)
(11)
(11)
(13)
(10)
(8)
(18)
(9)
(10)
(16)
(29)
(8)
(12)
(12)
(13)
(8)
(9)
(7)
(28)
(9)
(16)
(7)
(29)
(7)
(8)
(8)
(11)
(16)
(16)
(12)
(35)
(8)
(11)
(16)
(18)
(9)
(29)
(9)
(14)
(22)
(31)
(11)
(7)
(7)
(10)
(7)
(18)
(9)
(7)
(9)
(7)
(7)
(7)
(11)
(9)
(23)
(20)
(10)
(7)
(7)
(15)
(10)
(8)
(37)
(8)
(22)
(10)
(16)
(11)
(10)
(24)
(13)
(7)
(11)
(7)
(9)
(11)
(9)
(12)
(21)
(9)
(9)
(7)
(11)
(7)
(16)
(9)
(7)
(9)
(12)
(19)
(13)
(7)
(7)
(7)
(11)
(10)
(7)
(9)
(24)
(7)
(8)
(10)
(12)
(8)
(13)
(25)
(23)
(7)
(24)
(16)
(9)
(7)
(10)
(9)
(8)
(8)
(13)
(9)
(9)
(10)
(7)
(10)
(7)
(20)
(8)
(9)
(7)
(18)
(17)
(11)
(10)
(12)
(9)
(12)
(7)
(9)
(7)
(9)
(18)
(8)
(12)
(8)
(8)
(8)
(13)
(7)
(7)
(8)
(15)
(7)
(17)
(17)
(16)
(8)
(20)
(7)
(8)
(11)
(11)
(21)
(8)
(11)
(10)
(13)
(9)
(8)
(7)
(12)
(8)
(15)
(9)
(11)
(7)
(15)
(12)
(17)
(16)
(7)
(18)
(24)
(11)
(7)
(7)
(12)
(8)
(19)
(20)
(16)
(11)
(12)
(7)
(8)
(10)
(14)
(16)
(7)
(9)
(11)
(20)
(15)
(9)
(16)
(48)
(9)
(11)
(24)
(11)
(8)
(9)
(7)
(10)
(9)
(7)
(10)
(8)
(53)
(13)
(9)
(11)
(15)
(42)
(16)
(8)
(8)
(29)
(10)
(7)
(10)
(8)
(8)
(24)
(8)
(11)
(12)
(8)
(13)
(21)
(24)
(10)
(10)
(16)
(20)
(11)
(10)
(15)
(17)
(12)
(18)
(7)
(17)
(16)
(10)
(15)
(18)
(14)
(16)
(22)
(7)
(9)
(17)
(12)
(15)
(8)
(18)
(20)
(15)
(11)
(29)
(7)
(10)
(23)
(7)
(7)
(27)
(8)
(7)
(26)
(18)
(8)
(12)
(11)
(8)
(36)
(15)
(12)
(7)
(8)
(15)
(16)
(7)
(7)
(9)
(10)
(9)
(17)
(7)
(12)
(12)
(13)
(12)
(16)
(9)
(13)
(8)
(15)
(24)
(8)
(8)
(8)
(7)
(17)
(9)
(7)
(28)
(12)
(15)
(13)
(9)
(7)
(7)
(9)
(8)
(7)
(8)
(14)
(9)
(14)
(17)
(7)
(8)
(7)
(10)
(11)
(7)
(16)
(9)
(59)
(12)
(8)
(8)
(7)
(7)
(9)
(7)
(18)
(7)
(8)
(18)
(9)
(15)
(10)
(8)
(25)
(11)
(8)
(9)
(14)
(26)
(23)
(8)
(43)
(11)
(14)
(7)
(15)
(11)
(20)
(7)
(28)
(15)
(10)
(9)
(26)
(18)
(7)
(8)
(8)
(7)
(18)
(15)
(15)
(11)
(7)
(8)
(7)
(10)
(14)
(8)
(30)
(15)
(7)
(9)
(19)
(18)
(15)
(9)
(7)
(7)
(8)
(13)
(11)
(15)
(17)
(8)
(49)
(7)
(32)
(13)
(10)
(16)
(7)
(23)
(24)
(9)
(10)
(25)
(8)
(20)
(7)
(7)
(13)
(7)
(11)
(9)
(7)
(7)
(10)
(9)
(8)
(9)
(7)
(7)
(10)
(16)
(14)
(12)
(7)
(10)
(7)
(20)
(9)
(15)
(7)
(11)
(12)
(11)
(13)
(8)
(7)
(19)
(26)
(17)
(7)
(15)
(9)
(8)
(18)
(17)
(8)
(8)
(12)
(7)
(10)
(7)
(9)
(8)
(18)
(18)
(11)
(8)
(35)
(21)
(7)
(7)
(18)
(9)
(7)
(10)
(7)
(10)
(9)
(14)
(14)
(10)
(24)
(12)
(8)
(53)
(7)
(7)
(19)
(8)
(10)
(7)
(10)
(8)
(11)
(7)
(9)
(8)
(8)
(20)
(13)
(27)
(8)
(8)
(19)
(7)
(19)
(7)
(11)
(7)
(12)
(7)
(11)
(11)
(28)
(10)
(9)
(7)
(20)
(10)
(13)
(7)
(8)
(9)
(13)
(11)
(10)
(7)
(13)
(9)
(7)
(10)
(8)
(7)
(7)
(10)
(14)
(9)
(38)
(23)
(10)
(8)
(7)
(10)
(11)
(10)
(13)
(15)
(10)
(7)
(17)
(10)
(7)
(7)
(11)
(11)
(12)
(8)
(10)
(18)
(14)
(8)
(10)
(21)
(16)
(14)
(14)
(9)
(15)
(9)
(19)
(24)
(11)
(20)
(21)
(16)
(7)
(7)
(10)
(23)
(7)
(8)
(17)
(7)
(9)
(10)
(7)
(7)
(17)
(8)
(8)
(7)
(9)
(9)
(13)
(10)
(8)
(13)
(9)
(13)
(8)
(18)
(7)
(7)
(27)
(12)
(8)
(15)
(9)
(17)
(8)
(18)
(7)
(26)
(12)
(9)
(9)
(19)
(10)
(7)
(7)
(13)
(7)
(7)
(8)
(10)
(21)
(15)
(35)
(14)
(18)
(7)
(7)
(7)
(8)
(21)
(16)
(24)
(24)
(18)
(8)
(7)
(18)
(12)
(7)
(7)
(13)
(25)
(7)
(8)
(12)
(11)
(19)
(7)
(27)
(18)
(10)
(10)
(8)
(12)
(7)
(7)
(7)
(10)
(7)
(7)
(10)
(16)
(12)
(10)
(7)
(18)
(7)
(25)
(10)
(15)
(10)
(18)
(24)
(13)
(16)
(9)
(19)
(13)
(26)
(16)
(18)
(8)
(10)
(8)
(10)
(14)
(7)
(10)
(7)
(13)
(7)
(7)
(11)
(17)
(7)
(15)
(13)
(13)
(13)
(8)
(33)
(8)
(11)
(11)
(8)
(11)
(12)
(21)
(10)
(9)
(12)
(23)
(8)
(11)
(14)
(8)
(19)
(11)
(8)
(8)
(11)
(9)
(8)
(11)
(10)
(8)
(8)
(14)
(13)
(10)
(16)
(9)
(30)
(11)
(11)
(10)
(14)
(23)
(8)
(9)
(12)
(11)
(10)
(8)
(8)
(9)
(20)
(17)
(12)
(10)
(8)
(18)
(13)
(17)
(11)
(9)
(29)
(10)
(9)
(13)
(11)
(8)
(29)
(13)
(13)
(9)
(11)
(40)
(8)
(10)
(12)
(14)
(8)
(13)
(16)
(9)
(12)
(8)
(9)
(11)
(8)
(9)
(40)
(10)
(9)
(20)
(17)
(8)
(24)
(13)
(10)
(24)
(9)
(18)
(20)
(9)
(9)
(8)
(8)
(29)
(15)
(8)
(73)
(9)
(38)
(8)
(23)
(10)
(24)
(9)
(12)
(9)
(8)
(10)
(12)
(11)
(8)
(22)
(9)
(13)
(10)
(16)
(8)
(9)
(13)
(17)
(11)
(8)
(12)
(15)
(9)
(9)
(13)
(9)
(8)
(20)
(14)
(33)
(9)
(16)
(10)
(10)
(10)
(12)
(8)
(9)
(33)
(16)
(8)
(10)
(8)
(11)
(13)
(14)
(21)
(10)
(15)
(8)
(8)
(12)
(8)
(15)
(12)
(18)
(9)
(12)
(13)
(13)
(23)
(11)
(15)
(12)
(9)
(8)
(8)
(13)
(25)
(13)
(17)
(8)
(13)
(11)
(13)
(11)
(9)
(10)
(8)
(10)
(21)
(13)
(21)
(23)
(25)
(8)
(9)
(11)
(11)
(15)
(10)
(13)
(10)
(9)
(19)
(14)
(10)
(15)
(28)
0 of 1000
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(5)
(4)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(9)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(2)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(9)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(16)
(1)
(1)
(14)
(7)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(33)
(1)
(2)
(106)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(13)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(13)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(2)
(68)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(8)
(1)
(4)
(3)
(5)
(6)
(2)
(1)
(11)
(1)
(2)
(3)
(1)
(4)
(7)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(12)
(1)
(3)
(1)
(3)
(1)
(1)
(126)
(1)
(2)
(1)
(1)
(4)
(22)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3943)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(2)
(3)
(1)
(3)
(1)
(1)
(1)
(2)
(11)
(10)
(1)
(1)
(41)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(14)
(1)
(1)
(4)
(20)
(1)
(7)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(13)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(7)
(2)
(1)
(1)
(2)
(1)
(65)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(6)
(5)
(1)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(33)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(3)
(21)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(425)
(1)
(1)
(1)
(2)
(1)
(1)
(5)
(1)
(3)
(1)
(1)
(6)
(1)
(6)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(3)
(5)
(2)
(2)
(2)
(4)
(3)
(3)
(4)
(2)
(2)
(2)
(3)
(3)
(9)
(2)
(2)
(2)
(2)
(2)
(9)
(7)
(4)
(2)
(2)
(5)
(2)
(12)
(2)
(7)
(12)
(4)
(2)
(3)
(4)
(2)
(3)
(4)
(2)
(5)
(4)
(7)
(2)
(5)
(7)
(2)
(9)
(4)
(2)
(4)
(9)
(2)
(2)
(2)
(2)
(4)
(2)
(8)
(9)
(3)
(3)
(2)
(2)
(5)
(2)
(5)
(4)
(3)
(2)
(9)
(4)
(4)
(3)
(6)
(4)
(2)
(3)
(2)
(6)
(2)
(2)
(11)
(3)
(2)
(2)
(2)
(3)
(2)
(10)
(2)
(4)
(8)
(2)
(15)
(2)
(2)
(3)
(20)
(6)
(2)
(2)
(5)
(2)
(13)
(11)
(2)
(24)
(2)
(3)
(3)
(7)
(2)
(3)
(3)
(3)
(2)
(9)
(2)
(14)
(2)
(7)
(3)
(4)
(3)
(2)
(3)
(9)
(5)
(9)
(50)
(8)
(3)
(13)
(3)
(3)
(2)
(4)
(3)
(9)
(5)
(2)
(2)
(3)
(2)
(15)
(9)
(5)
(4)
(2)
(5)
(4)
(5)
(4)
(5)
(5)
(11)
(4)
(12)
(5)
(2)
(2)
(7)
(5)
(3)
(3)
(2)
(5)
(2)
(2)
(2)
(3)
(2)
(3)
(2)
(7)
(2)
(2)
(3)
(3)
(3)
(6)
(2)
(3)
(3)
(10)
(2)
(16)
(2)
(7)
(9)
(6)
(4)
(7)
(5)
(4)
(11)
(3)
(4)
(13)
(17)
(2)
(2)
(149)
(24)
(2)
(2)
(4)
(8)
(7)
(11)
(8)
(5)
(3)
(13)
(4)
(17)
(6)
(9)
(2)
(22)
(2)
(2)
(6)
(3)
(9)
(4)
(2)
(3)
(15)
(3)
(4)
(3)
(6)
(8)
(15)
(2)
(23)
(2)
(2)
(4)
(5)
(5)
(24)
(2)
(4)
(2)
(7)
(2)
(2)
(9)
(3)
(2)
(9)
(6)
(11)
(5)
(15)
(4)
(2)
(3)
(5)
(6)
(2)
(118)
(5)
(18)
(3)
(2)
(7)
(125)
(2)
(3)
(2)
(5)
(7)
(2)
(3)
(2)
(4)
(6)
(3)
(3)
(2)
(3)
(2)
(6)
(10)
(12)
(2)
(3)
(3)
(4)
(4)
(9)
(2)
(2)
(2)
(5)
(6)
(4)
(2)
(2)
(2)
(2)
(2)
(4)
(13)
(4)
(2)
(3)
(2)
(9)
(4)
(2)
(2)
(2)
(7)
(2)
(2)
(2)
(2)
(2)
(3)
(2)
(4)
(3)
(3)
(3)
(4)
(2)
(12)
(4)
(2)
(5)
(6)
(5)
(2)
(3)
(14)
(4)
(2)
(2)
(2)
(2)
(14)
(7)
(2)
(2)
(3)
(3)
(2)
(2)
(7)
(44)
(183)
(2)
(88)
(115)
(2)
(8)
(2)
(3)
(26)
(80)
(2)
(2)
(22)
(3)
(2)
(36)
(30)
(10)
(8)
(16)
(10)
(5)
(2)
(14)
(180)
(2)
(3)
(3)
(2)
(93)
(6)
(2)
(2)
(4)
(317)
(7)
(11)
(2)
(6)
(4)
(3)
(3)
(6)
(2)
(4)
(4)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(4)
(2)
(2)
(4)
(2)
(3)
(2)
(2)
(2)
(2)
(3)
(2)
(5)
(4)
(2)
(2)
(2)
(2)
(4)
(4)
(2)
(3)
(15)
(3)
(2)
(2)
(14)
(2)
(5)
(2)
(6)
(15)
(13)
(4)
(2)
(3)
(5)
(2)
(8)
(2)
(4)
(2)
(2)
(3)
(3)
(7)
(4)
(2)
(2)
(4)
(2)
(2)
(4)
(2)
(2)
(2)
0 of 1000
(2)
(1)
(111)
(8)
(1)
(2855)
(2004)
(4)
(13)
(34)
(81)
(3)
(1)
(1)
(2)
(3)
(19)
(1)
(46)
(4167)
(2)
(4)
(2)
0 of 23
(1)
(15)
(33)
(8)
(13)
(1)
(8)
(2)
(2)
(4)
(5)
(25)
(1)
(2)
(180)
(1)
(114)
(2)
(3)
(7)
(1)
(3)
(10)
(11)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(168)
(159)
(1)
(1)
(1)
(1)
(20)
(1)
(28)
(1)
(1)
(2)
(1)
(23)
(2)
(1)
(1)
(1)
(1)
(23)
(8)
(1)
(2)
(3)
(1)
(6)
(1)
(19)
(1)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(3)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(12)
(1)
(1)
(1)
(2)
(1)
(1)
(16)
(1)
(3)
(1)
(20)
(1)
(5)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(2)
(2)
(2)
(1)
(871)
(2)
(1)
(11)
(1)
(3)
(6)
(1)
(1)
(1)
(87)
(4)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(2)
(1)
(14)
(3)
(4)
(53)
(1)
(1)
(1)
(1)
(8)
(17)
(1)
(1)
(1)
(1)
(7)
(1)
(8)
(266)
(1)
(7)
(1)
(1)
(3)
(201)
(2)
(2)
(1)
(1)
(4)
(1)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(2)
(2)
(39)
(1)
(1)
(17)
(13)
(1)
(5)
(1)
(2)
(11)
(1)
(1)
(177)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(4)
(1)
(7)
(1)
(4)
(1)
(1)
(68)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(39)
(2)
(1)
(1)
(5)
(3)
(12)
(316)
(1)
(1)
(1)
(1)
(28)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(468)
(3)
(6)
(42)
(1)
(3)
(12)
(5)
(4)
(10)
(1)
(1)
(20)
(1)
(8)
(1)
(1)
(1)
(3)
(2)
(15)
(14)
(8)
(2)
(18)
(1)
(112)
(1)
(1)
(1)
(1)
(4)
(5)
(24)
(1)
(1)
(9)
(1)
(3)
(76)
(307)
(1)
(1)
(1)
(31)
(161)
(12)
(1)
(174)
(3)
(3)
(10)
(7)
(25)
(1)
(1)
(1)
(4)
(23)
(42)
(1)
(1)
(1)
(1)
(111)
(1)
(1)
(1)
(1)
(213)
(18)
(1)
(1)
(9)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(4)
(1)
(1)
(1)
(1)
(4)
(32)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(13)
(3)
(1)
(4)
(5)
(96)
(1)
(2)
(209)
(1)
(3)
(2)
(2)
(3)
(1)
(1)
(127)
(9)
(7)
(3)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(204)
(1)
(1)
(272)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(55)
(1)
(1)
(1)
(1)
(1)
(5)
(265)
(12)
(5)
(3)
(11)
(1)
(8)
(1)
(3)
(1)
(1)
(3)
(1)
(306)
(1)
(131)
(1)
(163)
(1)
(1)
(1)
(77)
(4)
(3)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(2)
(1)
(3)
(1)
(2)
(3)
(3)
(112)
(1)
(1)
(9)
(2)
(27)
(34)
(1)
(1)
(3)
(18)
(60)
(1)
(237)
(2)
(1)
(187)
(2)
(1)
(5)
(1)
(500)
(6)
(1)
(7)
(1)
(1)
(156)
(5)
(1)
(16)
(2)
(1)
(6)
(3)
(2)
(1)
(1)
(3)
(3)
(5)
(9)
(4)
(31)
(1)
(1)
(4)
(1)
(248)
(45)
(4)
(1)
(1)
(2)
(1)
(10)
(8)
(5)
(2)
(1)
(1)
(1)
(57)
(72)
(80)
(241)
(256)
(318)
(52)
(45)
(51)
(88)
(1)
(1)
(1)
(1)
(1)
(558)
(114)
(1)
(1)
(4)
(10)
(1)
(1)
(267)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(7)
(8)
(31)
(8)
(7)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(301)
(1)
(1)
(13)
(10)
(2)
(1)
(27)
(1)
(1)
(1)
(1)
(18)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(19)
(1)
(1)
(1)
(5)
(16)
(1)
(2)
(1)
(154)
(1)
(1)
(1)
(5)
(1)
(9)
(1)
(1)
(3)
(2)
(1)
(90)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(5)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(11)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(3)
(1)
(4)
(1)
(4)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(18)
(13)
(1)
(14)
(1)
(1)
(13)
(11)
(1)
(2)
(1)
(117)
(46)
(4)
(8)
(2)
(1)
(9)
(4)
(20)
(1)
(2)
(2)
(1)
(5)
(2)
(1)
(2)
(1)
(14)
(1)
(1)
(1)
(1)
(2)
(2)
(22)
(24)
(1)
(1)
(1)
(3)
(1)
(18)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(1)
(185)
(1)
(1)
(481)
(22)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(11)
(8)
(1)
(1)
(1)
(7)
(1)
(1)
(130)
(1)
(11)
(27)
(1)
(1)
(1)
(67)
(7028)
(1)
(11)
(1)
(5)
(154)
(1)
(1)
(11)
(79)
(1)
(1)
(3)
(3)
(31)
(1)
(4)
(2)
(4)
(215)
(1)
(1)
(30)
(2)
(1)
(390)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(256)
(1)
(1)
(3)
(1)
(1)
(195)
(1)
(1)
(2)
(1)
(45)
(1)
(3)
(9)
(6)
(8)
(9)
(1)
(2)
(1)
0 of 775
(1)
(55)
(9)
(1)
(2)
(25)
(295)
(2)
(2)
(2)
(3)
(1)
(5)
(27)
(1)
(3)
(5)
(14)
(60)
(10)
(1)
(2)
(4)
(1)
(787)
(2803)
(3)
(5)
(5)
(37)
(1)
(16)
(1)
(7)
(3)
(16)
(3)
(27)
(1)
(108)
(2)
(383)
(51)
(1)
(1)
(1)
(1)
(2004)
(1)
(4)
(1)
(8)
(344)
(4)
(3)
(48)
(3)
0 of 57
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(8)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
0 of 794
(82)
(4)
(1)
(6)
0 of 4
Showing 1221 - 1240 of 9551 results
  • Association Between K12 School Mask Policies and Schoolassociated COVID19 Outbreaks Maricopa and Pima Counties Arizona JulyAugust 2021
    Association Between K–12 School Mask Policies and School-associated COVID-19 Outbreaks — Maricopa and Pima Counties, Arizona, July–August 2021
    Jehn, Mega ;
    McCullough, J. Mac
    September 24, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    CDC recommends universal indoor masking by students, staff members, faculty, and visitors in kindergarten through grade 12 (K–12) schools, regardless of vaccination status, to reduce Transmission of SARS-CoV-2, the Virus that causes COVID-19 (1). Schools in Maricopa and Pima Counties, which account for >75% of Arizona’s population (2), resumed in-p ...
    Supporting Files Public Domain
  • Supplementary FigureCOVID19related K12 school learning modality by region and stateUnited States August 2September 17 2021
    Supplementary Figure. COVID-19-related K-12 school learning modality, by region and state — United States, August 2–September 17, 2021 
    Centers for Disease Control and Prevention (U.S.)
    09/24/2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
  • Supplementary Table SARSCoV2 Attack Rates Among Incarcerated Persons by Vaccination Characteristics and History of Prior COVID19 Federal Prison Texas July 12August 14 2021
    Supplementary Table. SARS-CoV-2 Attack Rates Among Incarcerated Persons by Vaccination Characteristics and History of Prior COVID-19 — Federal Prison, Texas, July 12–August 14, 2021
    Centers for Disease Control and Prevention (U.S.)
    09/21/2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • SARSCoV2 B16172 Delta Variant Outbreak Among Incarcerated Persons in a Federal Prison Texas JulyAugust 2021
    SARS-CoV-2 B.1.617.2 (Delta) Variant Outbreak Among Incarcerated Persons in a Federal Prison — Texas, July–August 2021
    Hagan, Liesl M. ;
    McCormick, David W.
    September 21, 2021  | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? Incarcerated populations have experienced disproportionately higher rates of COVID-19–related illness and death.What is added by this report? During a COVID-19 outbreak involving the Delta Variants in a highly vaccinated incarcerated population, Transmission rates were high, even among vaccinated persons. Alt ...
    Supporting Files Public Domain
  • Use of PfizerBioNTech COVID19 Vaccine in Persons Aged 16 Years Recommendations of the Advisory Committee on Immunization Practices United States September 2021
    Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021
    Dooling, Kathleen ;
    Gargano, Julia W.
    September 21, 2021  | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? On August 23, 2021, the Food and Drug Administration granted full approval of the Pfizer-BioNTech COVID-19 vaccine for persons aged ≥16 years.What is added by this report? On August 30, 2021, after a systematic review of the data, the Advisory Committee on Immunization Practices revised its interim recommenda ...
    Supporting Files Public Domain
  • Interim Estimates of COVID19 Vaccine Effectiveness Against COVID19Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARSCoV2 B16172 Delta Variant Predominance Nine States JuneAugust 2021
    Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021
    Grannis, Shaun J. ;
    Rowley, Elizabeth A.
    9 17 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Data on COVID-19 vaccine effectiveness (VE) since the B.1.617.2 (Delta) Variants of SARS-CoV-2, the Virus that causes COVID-19, became the predominant circulating strain in the U.S. are limited (1-3). CDC used the VISION Network* to examine medical encounters (32,867) from 187 hospitals and 221 emergency departments (EDs) and urgent care (UC) clini ...
    Supporting Files Public Domain
  • New COVID19 Cases and Hospitalizations Among Adults by Vaccination Status New York May 3July 25 2021
    New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021
    Rosenberg, Eli S. ;
    Holtgrave, David R.
    9 17 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Data from randomized clinical trials and real-world observational studies show that all three COVID-19 vaccines currently authorized for emergency use by the Food and Drug Administration* are safe and highly effective for preventing COVID-19-related serious illness, hospitalization, and death (1,2). Studies of vaccine effectiveness (VE) for prevent ...
    Supporting Files Public Domain
  • Correction and Republication New COVID19 Cases and Hospitalizations Among Adults by Vaccination Status New York May 3July 25 2021
    Correction and Republication: New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021
    9 17 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    On, August 18, 2021, MMWR published "New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021" (1). On August 25, 2021, the authors informed MMWR that some analyses were inaccurate because vaccination records of persons with a birth date between two vaccination dates could be counted as two distinc ...
    Supporting Files Public Domain
  • Effectiveness of COVID19 mRNA Vaccines Against COVID19Associated Hospitalization Five Veterans Affairs Medical Centers US February 1August 6 2021
    Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalization — Five Veterans Affairs Medical Centers, U.S. February 1–August 6, 2021
    Bajema, Kristina L. ;
    Dahl, Rebecca M.
    9 17 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) have been shown to be highly protective against COVID-19-associated hospitalizations (1-3). Data are limited on the level of protection against hospitalization among disproportionately affected populations in the U.S. particularly during periods in which the B.1.617.2 (Delta) Variants of SARS-CoV ...
    Supporting Files Public Domain
  • PostAcute Sequelae of SARSCoV2 Infection Among Adults Aged 18 Years Long Beach California April 1December 10 2020
    Post-Acute Sequelae of SARS-CoV-2 Infection Among Adults Aged ≥18 Years — Long Beach, California, April 1–December 10, 2020
    Yomogida, Kyle ;
    Zhu, Sophie
    9 17 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Post-acute sequelae of COVID-19, also known as "long COVID," is used to describe the long-term symptoms that might be experienced weeks to months after primary infection with SARS-CoV-2, the Virus that causes COVID-19. Among persons with a previous COVID-19 Diagnosis, estimates of the prevalence of sequelae range from 5% among nonhospitalized perso ...
    Supporting Files Public Domain
  • Notes From the Field Xylazine Detection and Involvement in Drug Overdose Deaths US 2019
    Notes From the Field: Xylazine Detection and Involvement in Drug Overdose Deaths — U.S. 2019
    Kariisa, Mbabazi ;
    Patel, Priyam
    9 17 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
  • Monitoring Incidence of COVID19 Cases Hospitalizations and Deaths by Vaccination Status 13 US Jurisdictions April 4July 17 2021
    Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021
    Scobie, Heather M. ;
    Johnson, Amelia G.
    9 17 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    COVID-19 vaccine breakthrough infection Surveillance helps monitor Trends in disease incidence and severe outcomes in fully vaccinated persons, including the impact of the highly transmissible B.1.617.2 (Delta) Variants of SARS-CoV-2, the Virus that causes COVID-19. Reported COVID-19 cases, hospitalizations, and deaths occurring among persons aged ...
    Supporting Files Public Domain
  • Disaggregating Data to Measure Racial Disparities in COVID19 Outcomes and Guide Community Response Hawaii March 1 2020February 28 2021
    Disaggregating Data to Measure Racial Disparities in COVID-19 Outcomes and Guide Community Response — Hawaii, March 1, 2020–February 28, 2021
    Quint, Joshua J. ;
    Van Dyke, Miriam E.
    9 17 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Native Hawaiian and Pacific Islander populations have been disproportionately affected by COVID-19 (1-3). Native Hawaiian, Pacific Islander, and Asian populations vary in language; cultural practices; and social, economic, and environmental experiences,| which can affect health outcomes (4).| However, data from these populations are often aggregate ...
    Supporting Files Public Domain
  • Morbidity and Mortality Weekly Report MMWR Surveillance Summaries September 2021 Vol 70 No SS5
    Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, September 2021 / Vol. 70 / No. SS-5
    Pate, Cynthia A. ;
    Zahran, Hatice S.
    September 17, 2021 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)
    ProblemAsthma is a chronic disease of the airways that requires ongoing medical management. Socioeconomic and demographic factors as well as health care use might influence health patterns in urban and rural areas. Persons living in rural areas tend to have less access to health care and health resources and worse health outcomes. Characterizing as ...
    Supporting Files Public Domain
  • Comparative Effectiveness of Moderna PfizerBioNTech and Janssen Johnson Johnson Vaccines in Preventing COVID19 Hospitalizations Among Adults Without Immunocompromising Conditions United States MarchAugust 2021
    Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021
    Self, Wesley H. ;
    Tenforde, Mark W.
    September 17, 2021  | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? Two 2-dose mRNA COVID-19 vaccines (from Pfizer-BioNTech and Moderna) and a 1-dose viral vector vaccine (from Janssen [Johnson & Johnson]) are currently used in the United StatesWhat is added by this report? Among U.S. adults without immunocompromising conditions, vaccine effectiveness against COVID-19 hospita ...
    Supporting Files Public Domain
  • QuickStats AgeAdjusted Death Rates for Cancer by UrbanRural Status and Sex National Vital Statistics System US United States 19992019
    QuickStats: Age-Adjusted Death Rates for Cancer, by Urban-Rural Status and Sex — National Vital Statistics System (U.S.), United States, 1999–2019
    Curtin, Sally C. ;
    Branum, PAmy M.
    9 17 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Cancer death rates declined among males and females during 1999–2019 in urban areas from 249.6 per 100,000 to 168.4 for males and from 168.2 to 123.9 for females. Rates also declined in rural areas from 262.4 to 195.6 for males and from 165.4 to 139.2 for females. Throughout the period, cancer death rates were higher for males than females and in r ...
    Supporting Files Public Domain
  • Longitudinal Trends in Body Mass Index Before and During the COVID19 Pandemic Among Persons Aged 219 Years United States 20182020
    Longitudinal Trends in Body Mass Index Before and During the COVID-19 Pandemic Among Persons Aged 2–19 Years — United States, 2018–2020
    Lange, Samantha J. ;
    Kompaniyets, Lyudmyla
    9 17 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Obesity is a serious health concern in the United States, affecting more than one in six children (1) and putting their long-term health and quality of life at risk.* During the COVID-19 pandemic, children and adolescents spent more time than usual away from structured school settings, and families who were already disproportionally affected by obe ...
    Supporting Files Public Domain
  • Supplementary Table 2 Predictors Associated With Having Fatigue and Dyspnea Logistic Regression 2 Months Following COVID19 Diagnosis N 363 Long Beach California April 1December 10 2020
    Supplementary Table 2. Predictors Associated With Having Fatigue and Dyspnea (Logistic Regression) 2 Months Following COVID-19 Diagnosis (N = 363) — Long Beach, California, April 1–December 10, 2020
    Centers for Disease Control and Prevention (U.S.)
    09/17/2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Supplementary Table 1 Clinical Severity of COVID19 Sequelae at 1 Month After Positive Test 2 Months After Positive Test and Date of Interview by Disease Severity at Diagnosis N 365 Long Beach California April 1December 10 2020
    Supplementary Table 1. Clinical Severity of COVID-19 Sequelae at 1 Month After Positive Test, 2 Months After Positive Test, and Date of Interview by Disease Severity at Diagnosis (N = 365) — Long Beach, California, April 1–December 10, 2020
    Centers for Disease Control and Prevention (U.S.)
    09/17/2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Correction New COVID19 Cases and Hospitalizations Among Adults by Vaccination Status New York May 3July 25 2021
    Correction: New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021
    Centers for Disease Control and Prevention (U.S.)
    09/17/2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Provides corrections to the August 18, 2021 article published in the early release v. 70.
    Public Domain
1221 - 1240 / 9551
 Was this page helpful?
 Found an issue?
Send us an email at: publishinghd@cdc.gov